Bromide, Butylscopolammonium,
Bromide, N-Butylscopolammonium,
Buscapine,
Buscolysin,
Buscopan,
Butylscopolamine,
Butylscopolammonium Bromide,
Hyoscinbutylbromide,
Hyoscine N Butylbromide,
Hyoscine N-Butylbromide,
N Butylscopolammonium Bromide,
N-Butylbromide, Hyoscine,
N-Butylscopolammonium Bromide,
Scopolaminebutylbromide,
Scopolan,
scopolamine butylbromide,
149-64-4,
Butylhyoscine,
Hyoscine butylbromide,
N-Butylscopolammonium bromide,
Sporamin,
Butylscopolamine bromide,
Monospan,
Scopolamine bromobutylate,
BUTYLSCOPOLAMMONIUM BROMIDE,
UNII-0GH9JX37C8,
Buscolamin,
Buscolysin,
Buscolysine,
Amisepan,
Buscapina,
Buscapine,
Buscopan,
Butylmin,
Donopon,
Joscine,
Scobron,
Scobutil,
Scobutyl,
Scopolan,
Sparicon,
Stilbron,
Tirantil,
Buscol,
Scobro,
MLS000069755,
0GH9JX37C8,
Hyoscine butobromide,
(-)-N-Butylscopolamine bromide,
Hyoscine butyl bromide,
Scopolamine butobromide,
(-)-SCOPOLAMINE N-BUTYL BROMIDE,
N-Butylhyoscine bromide,
Hyoscin-N-butyl bromide,
SMR000058795,
Hyoscine-N-butyl bromide,
Scopolamine butyl bromide,
N-Butylhyoscinium bromide,
N-Butylscopolamine bromide,
DSSTox_CID_2718,
Scopolamine N-butyl bromide,
N-Butylscopolaminium bromide,
DSSTox_RID_76697,
DSSTox_GSID_22718,
Butylscopolamine bromide [JAN],
Hyoscin-N-butylbromid [German],
EINECS 205-744-1,
CAS-149-64-4,
Hyoscine N-butyl bromide,
Hyoscin-N-butylbromid,
Scopolamine N-n-butylbromide,
butylscopolamin,
SR-01000759230,
(1?,2?,4?,5?,7?)-9-Butyl-7-[(2S)-3-hydroxy-1-oxo-2-phenylpropoxy]-9-methyl-3-oxa-9-azoniatricyclo[3.3.1.02,4]nonane bromide,
butylscopolaminebromide,
butylscopolamine-bromide,
Opera_ID_556,
scopolamine n-butylbromide,
NCGC00163224-01,
Scopolamine (butylbromide),
C21H30BrNO4,
Hyoscine-N-Butyl Bromide Bp,
SCHEMBL25291,
MLS002153372,
MLS006013629,
CHEMBL1256901,
DTXSID1022718,
HMS2235K20,
HMS3714I19,
1-alpha-H,5-alpha-H-Tropanium, 8-butyl-6-beta,7-beta-epoxy-3-alpha-hydroxy-, bromide, (-)-tropate,
3-Oxa-9-azoniatricyclo(3.3.1.02,4)nonane, 9-butyl-7-(3-hydroxy-1-oxo-2-phenylpropoxy)-9-methyl-, bromide, (7(S)-(1alpha,2beta,4beta,5alpha,7beta))-,
HY-N0340,
Tox21_112031,
Scopolamine butylbromide;Butylhyoscine,
AKOS016009548,
AKOS022168219,
Tox21_112031_1,
API0002957,
CCG-208412,
CS-3142,
DB09300,
EBD2197820,
NCGC00186628-02,
SC-19978,
SMR004705104,
AB2000556,
ST2407568,
C-22357,
J-008603,
SR-01000759230-3,
(-)-Scopolamine N-butyl bromide, >=98% (TLC), powder,
UNII-0GH9JX37C8 component HOZOZZFCZRXYEK-NUZVBNNJSA-M,
UNII-0GH9JX37C8 component HOZOZZFCZRXYEK-UBNOCOESSA-M,
Hyoscine butylbromide, British Pharmacopoeia (BP) Reference Standard,
Hyoscine butylbromide, European Pharmacopoeia (EP) Reference Standard,
(1R,2R,4S,5S,7R)-9-butyl-7-{[(2S)-3-hydroxy-2-phenylpropanoyl]oxy}-9-methyl-3-oxa-9-azatricyclo[3.3.1.0^{2,4}]nonan-9-ium bromide,
(1R,2R,4S,5S,7S)-9-butyl-7-{[(2S)-3-hydroxy-2-phenylpropanoyl]oxy}-9-methyl-3-oxa-9-azoniatricyclo[3.3.1.0~2,4~]nonane bromide,
[7(S)-(1alpha,2beta,4beta,5alpha,7beta)]-9-butyl-7-(3-hydroxy- 1-oxo-2-phenylpropoxy)-9-methyl-3-oxa- 9-azonitricyclo[3.3.1.0(2,4)]nonane,
scopolamine,
Butylscopolamine,
Scopolamine-N-butyl Bromide,
C21H30NO4.Br,
(-)scopolamine N-butyl bromide,
C21-H30-N-O4.Br,
MFCD00078561,
ACN-048734,
CID6852391,
R028,
3-Oxa-9-azoniatriciclo [3.3.1.02,4] nonano, 9-butil-7-[(2S)-3-hidroxi-1-oxo-2-fenilpropoxi]-9-metil-, bromuro (1:1 ), (1alfa, 2beta, 4beta, 5alfa, 7beta)-,
3-Oxa-9-azoniatricyclo[3.3.1.02,4]nonane, 9-butyl-7-(3-hydroxy-1-oxo-2-phenylpropoxy)-9-methyl-, bromide, [7(S)-(1.alpha.,2.beta.,4.beta.,5.alpha.,7.beta.)]-,
3-Oxa-9-azoniatricyclo[3.3.1.02,4]nonane, 9-butyl-7-[(2S)-3-hydroxy-1-oxo-2-phenylpropoxy]-9-methyl-, bromide, (1.alpha.,2.beta.,4.beta.,5.alpha.,7.beta.)-,
51-34-3,